Health Catalyst CEO Kohl Simeon received 2,747,385 shares at $0 on September 14, 2026, and bought 59,000 shares at $1.79, taking his reported holding to 2,856,385 shares. The transactions give investors separate award and purchase details, including the resulting holdings and the percentages represented by each transaction.
Key Highlights
- Kohl Simeon’s holding stood at 2,797,385 shares after the Equity award.
- The award represented about 98.2% of his resulting shareholding.
- His separate purchase represented about 2.1% of his resulting holding.
Health Catalyst, Inc. (NASDAQ: HCAT) Chief Executive Officer Kohl Simeon received 2,747,385 shares at $0 on September 14, 2026, while also buying company stock that day.
Award and Purchase Details
Simeon’s resulting holding after that transaction was 2,797,385 shares, with the award representing about 98.2% of that position. Following the purchase, Simeon’s reported holding was 2,856,385 shares. That purchase represented about 2.1% of the resulting holding.
FAQs
Q: What shares did Kohl Simeon receive from Health Catalyst?
A: Kohl Simeon received 2,747,385 Health Catalyst shares at $0 on September 14, 2026. The award represented about 98.2% of his resulting 2,797,385-share holding.
Q: How many Health Catalyst shares did Kohl Simeon own after the transactions?
A: Simeon’s reported holding was 2,797,385 shares after the award and 2,856,385 shares after the purchase. The figures correspond to separate transactions.
Q: What was Kohl Simeon’s Health Catalyst purchase price?
A: The article does not state Kohl Simeon’s purchase price for the company stock he bought. It states that the 2,747,385 shares he received were awarded at $0.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.